Gain Therapeutics Inc. (GANX)
| Sector: | NA |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 667 |
| % of all portfolios: | 0.001% |
| History | Portfolio Manager | Activity | Share change | % change to portfolio ▲ | |
| Q1 2024 | |||||
| ≡ | David Einhorn - Greenlight Capital | Reduce 3.79% | 22,280 | 0.00 | |
| Q3 2023 | |||||
| ≡ | David Einhorn - Greenlight Capital | Add 7.66% | 41,850 | 0.01 | |
| Q1 2021 | |||||
| ≡ | David Einhorn - Greenlight Capital | Buy | 546,560 | 0.57 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.